ATC
IBB icon

Argent Trust Co’s iShares Biotechnology ETF IBB Stock Holding History

Argent Trust Co’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$308K Sell
1,618
-94
-5% -$16.2K 0.01% 636
2026
Q1 		$289K Buy
1,712
+100
+6% +$17.1K 0.01% 618
2025
Q4 		$272K Sell
1,612
-21
-1% -$3.41K 0.01% 613
2025
Q3 		$236K Buy
1,633
+21
+1% +$2.87K 0.01% 636
2025
Q2 		$204K Hold
1,612
– – 0.01% 667
2025
Q1 		$206K Buy
1,612
+35
+2% +$4.75K 0.01% 657
2024
Q4 		$208K Buy
1,577
+40
+3% +$5.62K 0.01% 657
2024
Q3 		$224K Sell
1,537
-50
-3% -$7.24K 0.01% 633
2024
Q2 		$218K Hold
1,587
– – 0.01% 632
2024
Q1 		$218K Buy
+1,587
New +$217K 0.01% 634

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Argent Trust Co's IBB Position: Q2 2026 in Review

Argent Trust Co reduced its iShares Biotechnology ETF (IBB) stake by 5.5% in Q2 2026, selling an estimated $16.2K and leaving 1,618 shares worth $308K. The position accounts for 0.01% of the portfolio, ranked #636.

Argent Trust Co first reported a position in IBB in Q1 2024 and has held it in 10 quarters since. 956 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Argent Trust Co held 1,618 shares of iShares Biotechnology ETF worth $308K as of Q2 2026.
  • Argent Trust Co sold 94 iShares Biotechnology ETF shares in Q2 2026, an estimated $16.2K.
  • iShares Biotechnology ETF made up 0.01% of Argent Trust Co's portfolio in Q2 2026, its #636 holding.
  • Argent Trust Co first reported a position in iShares Biotechnology ETF in Q1 2024 and has held it in 10 quarters since.
  • 956 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Argent Trust Co's 13F filing for Q2 2026, filed 6 Aug 2026.